By Wilson Lau, President, Nuherbs05.11.22
China has recently locked down several major cities in its response to a COVID-19 outbreak. You may know Shanghai (population of 28 million plus), and you may not know the other cities such as Changchun (over 4 million), but China basically locked down more people than live in the 10 biggest cities in the U.S.
Why? It’s due to China’s zero-COVID policy, or I should say its “dynamic” zero-COVID policy, which is trying to use testing and strict quarantines to control COVID outbreaks. This policy, although draconian, has worked well to prevent infections from spreading prior to this year and the arrival of omicron. In fact, the practice of strict lockdowns has worked so well that very few people as a percentage of their population have actually had COVID, meaning there isn’t much natural immunity in China.
You might think that wouldn’t be much of an issue because over 80% of China’s population is vaccinated. You would be right, if China’s vaccine was effective against the omicron strain, but it isn’t. Thus, China is facing a huge immunity gap, with almost all of its population with little or no defense
Why? It’s due to China’s zero-COVID policy, or I should say its “dynamic” zero-COVID policy, which is trying to use testing and strict quarantines to control COVID outbreaks. This policy, although draconian, has worked well to prevent infections from spreading prior to this year and the arrival of omicron. In fact, the practice of strict lockdowns has worked so well that very few people as a percentage of their population have actually had COVID, meaning there isn’t much natural immunity in China.
You might think that wouldn’t be much of an issue because over 80% of China’s population is vaccinated. You would be right, if China’s vaccine was effective against the omicron strain, but it isn’t. Thus, China is facing a huge immunity gap, with almost all of its population with little or no defense
Continue reading this story and get 24/7 access to Nutraceuticals World for FREE
FREE SUBSCRIPTION
